5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
127.85%
Gross profit growth similar to METSB.HE's 127.85%. Walter Schloss would assume both firms track common industry trends.
-4.11%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.11%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-9.81%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.92%
Share count expansion well above METSB.HE's 1.92%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.92%
Diluted share count expanding well above METSB.HE's 1.92%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-133.84%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-273.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-32.13%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-34.81%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-4.61%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-209.24%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-165.31%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-159.11%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
120.17%
Similar net income/share CAGR to METSB.HE's 120.17%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-12.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
250.00%
3Y net income/share CAGR similar to METSB.HE's 250.00%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
-1.01%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
38.46%
3Y equity/share CAGR similar to METSB.HE's 38.46%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
42.10%
AR growth well above METSB.HE's 42.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.75%
Inventory growth well above METSB.HE's 9.75%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.51%
Similar asset growth to METSB.HE's 0.51%. Walter Schloss finds parallel expansions or investment rates.
-5.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
5.85%
Debt growth far above METSB.HE's 5.85%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.